Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2008 3
2009 1
2010 1
2011 2
2012 3
2013 2
2014 6
2015 3
2016 4
2017 3
2018 3
2019 6
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments.
Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI. Parfenov VA, et al. Among authors: epstein oi. Neuropsychiatr Dis Treat. 2019 May 21;15:1381-1402. doi: 10.2147/NDT.S197032. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31190841 Free PMC article. Review.
Insights into the Mechanism of Action of Highly Diluted Biologics.
Tarasov SA, Gorbunov EA, Don ES, Emelyanova AG, Kovalchuk AL, Yanamala N, Schleker ASS, Klein-Seetharaman J, Groenestein R, Tafani JP, van der Meide P, Epstein OI. Tarasov SA, et al. Among authors: epstein oi. J Immunol. 2020 Sep 1;205(5):1345-1354. doi: 10.4049/jimmunol.2000098. Epub 2020 Jul 29. J Immunol. 2020. PMID: 32727888
Structure-Based Design of Potent and Selective CK1γ Inhibitors.
Huang H, Acquaviva L, Berry V, Bregman H, Chakka N, O'Connor A, DiMauro EF, Dovey J, Epstein O, Grubinska B, Goldstein J, Gunaydin H, Hua Z, Huang X, Huang L, Human J, Long A, Newcomb J, Patel VF, Saffran D, Serafino R, Schneider S, Strathdee C, Tang J, Turci S, White R, Yu V, Zhao H, Wilson C, Martin MW. Huang H, et al. Among authors: epstein o. ACS Med Chem Lett. 2012 Oct 18;3(12):1059-64. doi: 10.1021/ml300278f. eCollection 2012 Dec 13. ACS Med Chem Lett. 2012. PMID: 24900428 Free PMC article.
Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Skarnovich MA, Emelyanova AG, Petrova NV, Borshcheva AA, Gorbunov EA, Mazurkov OY, Skarnovich MO, Tarasov SA, Shishkina LN, Epstein OI. Skarnovich MA, et al. Among authors: epstein oi. Antivir Ther. 2017;22(4):345-351. doi: 10.3851/IMP3115. Epub 2016 Dec 7. Antivir Ther. 2017. PMID: 27924780 Retracted.
Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.
Petrova NV, Emelyanova AG, Gorbunov EA, Edwards MR, Walton RP, Bartlett NW, Aniscenko J, Gogsadze L, Bakhsoliani E, Khaitov MR, Johnston SL, Tarasov SA, Epstein OI. Petrova NV, et al. Among authors: epstein oi. Antiviral Res. 2017 Jun;142:185-192. doi: 10.1016/j.antiviral.2017.03.017. Epub 2017 Mar 27. Antiviral Res. 2017. PMID: 28356234 Free article. Retracted.
42 results